These data demonstrated extensive co-localization of LPAR3 with CD44 and EpCAM in the HCC-NTL margin (Figure 3) in the absence of LPAR3-Hep par1 co-localization (Figure 3). This evidence concerns the gene LPAR3 and hepatocellular carcinoma.